<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="pmc-domain-id">1559</journal-id><journal-id journal-id-type="pmc-domain">viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474444</article-id><article-id pub-id-type="pmcid-ver">PMC12474444.1</article-id><article-id pub-id-type="pmcaid">12474444</article-id><article-id pub-id-type="pmcaiid">12474444</article-id><article-id pub-id-type="pmid">41012671</article-id><article-id pub-id-type="doi">10.3390/v17091243</article-id><article-id pub-id-type="publisher-id">viruses-17-01243</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Molecular Characterization and Epidemiology of Human Noroviruses in the Sverdlovsk Region, Russian Federation</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0000-2820-9867</contrib-id><name name-style="western"><surname>Bykov</surname><given-names initials="R">Roman</given-names></name><xref rid="af1-viruses-17-01243" ref-type="aff">1</xref><xref rid="c1-viruses-17-01243" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2113-6543</contrib-id><name name-style="western"><surname>Itani</surname><given-names initials="T">Tarek</given-names></name><xref rid="af1-viruses-17-01243" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0000-7092-3036</contrib-id><name name-style="western"><surname>Pletenchuk</surname><given-names initials="D">Daria</given-names></name><xref rid="af1-viruses-17-01243" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8214-7828</contrib-id><name name-style="western"><surname>Ohlopkova</surname><given-names initials="O">Olesia</given-names></name><xref rid="af2-viruses-17-01243" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1182-8247</contrib-id><name name-style="western"><surname>Moshkin</surname><given-names initials="A">Alexey</given-names></name><xref rid="af2-viruses-17-01243" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-2658-7746</contrib-id><name name-style="western"><surname>Stepanyuk</surname><given-names initials="M">Marina</given-names></name><xref rid="af2-viruses-17-01243" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3223-8219</contrib-id><name name-style="western"><surname>Semenov</surname><given-names initials="A">Aleksandr</given-names></name><xref rid="af1-viruses-17-01243" ref-type="aff">1</xref><xref rid="af3-viruses-17-01243" ref-type="aff">3</xref><xref rid="af4-viruses-17-01243" ref-type="aff">4</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Desselberger</surname><given-names initials="U">Ulrich</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-17-01243"><label>1</label>Federal Budgetary Institution of Science, &#171;Federal Scientific Research Institute of Viral Infections &#171;Virome&#187;&#187;, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Ekaterinburg 620030, Russia; <email>itani_tm@niivirom.ru</email> (T.I.); </aff><aff id="af2-viruses-17-01243"><label>2</label>Research Institute of Virology, Federal State Budgetary Scientific Institution &#171;Federal Research Center for Fundamental and Translational Medicine&#187;, Novosibirsk 630060, Russia</aff><aff id="af3-viruses-17-01243"><label>3</label>Department of Medical Microbiology and Clinical Laboratory Diagnostics, Ural State Medical University, Ekaterinburg 620109, Russia</aff><aff id="af4-viruses-17-01243"><label>4</label>Institute of Natural Sciences and Mathematics, Ural Federal University Named After the First President of Russia B.N. Yeltsin, Ekaterinburg 620075, Russia</aff><author-notes><corresp id="c1-viruses-17-01243"><label>*</label>Correspondence: <email>bykov_ro@niivirom.ru</email>; Tel.: +7-(982)-690-69-64</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497677</issue-id><elocation-id>1243</elocation-id><history><date date-type="received"><day>07</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>02</day><month>9</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 18:25:14.327"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="viruses-17-01243.pdf"/><abstract><p>Human noroviruses (HuNoVs) stand as the primary cause of acute viral gastroenteritis outbreaks worldwide, particularly impacting children under the age of five. In Russia, reports of norovirus gastroenteritis have surged, especially in the post-COVID-19 era starting in 2022, with elevated infection rates reported into 2024. These viruses exhibit significant mutational variability, leading to the emergence of recombinant strains that can evade immune responses. A comprehensive examination of the complete genome is crucial for understanding the evolution of norovirus genes and for predicting potential outbreaks. This research focuses on analyzing the genotypic composition of HuNoVs circulating in the Sverdlovsk region during 2024, using Sanger sequencing and next-generation sequencing (NGS). Biological samples were collected (n = 384) from patients diagnosed with norovirus infection within the region. Bioinformatics analysis targeted the nucleotide sequences of the ORF1/ORF2 fragment and the assembly of complete genomes for the GII.4 and GII.7 genotypes. In total, 220 HuNoVs were characterized, representing 57.3% of the collected samples. The main capsid variants forming the predominant genotypic profile included GII.4 (n = 88, 40%), GII.7 (n = 86, 39%), and GII.17 (n = 14, 6%). Using NGS, we successfully assembled 8 out of 10 complete genomes for noroviruses GII.4[P16] and GII.7[P7]. Non-synonymous substitutions appeared at amino acid sites corresponding to the subdomains of VP1 in these strains. This molecular&#8211;genetic analysis provides contemporary insights into the genotypic composition, circulation patterns, and evolutionary dynamics associated with the dominant genovariants GII.4[P16] and GII.7[P7].</p></abstract><kwd-group><kwd>next-generation sequencing (NGS)</kwd><kwd>HuNoVs GII.7[P7] and GII.4[P16]</kwd><kwd>phylogenetic analysis</kwd><kwd>non-synonymous mutations</kwd><kwd>genotypic composition</kwd></kwd-group><funding-group><award-group><funding-source>Federal Service for Surveillance on Consumer</funding-source></award-group><award-group><funding-source>Rights Protection and Human Wellbeing</funding-source><award-id>123051100045-0</award-id></award-group><award-group><funding-source>Research Institute of Virology, Federal State Budgetary Scientific Institution &#8220;Federal Research Center for Fundamental and Translational Medicine&#8221;</funding-source><award-id>125032404373-4</award-id></award-group><funding-statement>This research was funded by the Russian Federal Service for Surveillance on Consumer. Rights Protection and Human Wellbeing (scientific study N&#186; 123051100045-0) and Research Institute of Virology, Federal State Budgetary Scientific Institution &#8220;Federal Research Center for Fundamental and Translational Medicine&#8221; (scientific study N&#186; 125032404373-4).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-17-01243"><title>1. Introduction</title><p>Human noroviruses (HuNoVs) serve as the primary etiological factor behind most outbreaks of acute viral gastroenteritis globally. The global burden from infectious diseases presents a significant challenge for public health, with approximately 655 million infections and 213,515 deaths reported annually in the human population. The highest rates of morbidity and mortality affect children under five years [<xref rid="B1-viruses-17-01243" ref-type="bibr">1</xref>,<xref rid="B2-viruses-17-01243" ref-type="bibr">2</xref>,<xref rid="B3-viruses-17-01243" ref-type="bibr">3</xref>].</p><p>In the Russian Federation, there is a continuous trend of increasing morbidity rates from norovirus gastroenteritis, particularly observed in the post-COVID-19 period. According to the published data from the State Report by Rospotrebnadzor, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, titled &#8220;Sanitary and Epidemiological Wellbeing in the Russian Federation in 2024&#8221;, the morbidity rate for HuNoVs in Russia reached 37.62 per 100,000 people by the end of 2024, reflecting a 9% increase compared to levels reported in 2023. The rise in HuNoV morbidity can be attributed to the shift in circulating viral genotypes within the Russian Federation from GII.17[P17] in 2023 to GII.7[P7] in 2024, as well as the expanded coverage of laboratory diagnostics for associated acute gastroenteritis (AGE) using molecular methods. Notably, children comprised 82% of the cases that were reported. The highest incidence of HuNoVs occurred among children aged one to two years, with a morbidity rate of 516.12 per 100,000 people. Among the regions of the Russian Federation, the Sverdlovsk region exhibits a concerning epidemiological situation regarding HuNoVs, ranking fourth in overall morbidity with a rate of 126.38 per 100,000 people [<xref rid="B4-viruses-17-01243" ref-type="bibr">4</xref>].</p><p>HuNoVs belong to the genus <italic toggle="yes">Norovirus</italic>, which is part of the family <italic toggle="yes">Caliciviridae</italic>. Their genome consists of single-stranded positive-sense RNA, which contains three main open reading frames (ORFs) that regulate the synthesis of viral proteins. ORF1 encodes the RNA-dependent RNA polymerase (RdRp) and other proteins involved in the replication cycle. ORF2 encodes the major capsid protein, VP1, while ORF3 encodes the minor capsid protein, VP2 [<xref rid="B5-viruses-17-01243" ref-type="bibr">5</xref>,<xref rid="B6-viruses-17-01243" ref-type="bibr">6</xref>]. The virus-encoded protein VPg is covalently linked to the 5&#8242; end of the genome, which plays an essential role in the initiation of translation factors in host cells. The 3&#8242; end features a polyadenylated tail. A key function in the penetration of norovirus virion into target cells is performed by the structural protein VP1, composed of a complex with domains, including the N/S domain and P domain [<xref rid="B7-viruses-17-01243" ref-type="bibr">7</xref>]. The N/S domain serves as a shell that participates in forming the icosahedral symmetry type for the capsid. The P domain can be conventionally divided into two domains, P1 and P2 [<xref rid="B8-viruses-17-01243" ref-type="bibr">8</xref>], which act as antigenic determinants and dictate the binding specificity to polysaccharide complexes on target cells (<xref rid="viruses-17-01243-f001" ref-type="fig">Figure 1</xref>). The norovirus genome exhibits high mutational variability due to recombination events in the regions connecting the two open reading frames, ORF1 and ORF2, as well as within ORF2 itself [<xref rid="B9-viruses-17-01243" ref-type="bibr">9</xref>].</p><p>Recombinational variability results in a wide variety of recombinant strains that can evade the adaptive immune response in humans. This situation necessitates routine molecular&#8211;genetic monitoring and annual updates to the genotypic composition of HuNoVs across various regions in Russia and epidemiologically significant areas in the world with high disease prevalence [<xref rid="B9-viruses-17-01243" ref-type="bibr">9</xref>].</p><p>To achieve a more objective assessment of divergent evolution events among circulating HuNoV genotypes and to forecast potential future outbreaks, a thorough analysis of the complete norovirus genome is necessary. Several limitations hinder NGS application for HuNoV sequencing such as low viral load and the absence of a sensitive cell culture model for norovirus cultivation, which prevents the acquisition of a high viral RNA concentration after extraction. The above-mentioned limitations present a significant challenge in the implementation of norovirus sequencing using NGS methods; thus, there is a need to develop alternative ways to address the existing difficulties. A viable solution to the identified challenges may be the viral analysis of the whole genome, which amplifies all RNA-containing microorganisms present in the studied sample. Another approach is the development of a specific primer panel to enrich the HuNoV genome. Therefore, this study aims to conduct molecular characterization of the circulating HuNoV genotypes in the Sverdlovsk region in 2024.</p></sec><sec id="sec2-viruses-17-01243"><title>2. Materials and Methods</title><sec id="sec2dot1-viruses-17-01243"><title>2.1. Stool Samples</title><p>In 2024, fecal sample collection was organized from patients aged between 1 and 23 years, diagnosed with norovirus infection, in municipalities across the Sverdlovsk region showing the highest HuNoV morbidity rates. The collection of stool samples from patients with a confirmed diagnosis of HuNoVs was organized in four municipalities during 2024: Ekaterinburg, Kamensk-Uralsky, Nizhny Tagil, and Sukhoy Log (<xref rid="viruses-17-01243-f002" ref-type="fig">Figure 2</xref>). Samples from patients were screened for HuNoVs by either an enzyme immunoassay (Norovirus-antigen-enzyme immunoassays-Best, Vector-Best, Novosibirsk, Russian Federation) or qPCR (AmpliSens<sup>&#174;</sup> Norovirus GI-GII-FL, Central Scientific Research Institute of Epidemiology, Moscow, Russian Federation) at the following facilities: The Ekaterinburg Consultative Diagnostic Center and the State Autonomous Healthcare Institution of the Sverdlovsk Region Children&#8217;s City Hospital (Kamensk-Uralsky). Only positive samples were submitted to the Federal Scientific Research Institute of Viral Infections&#8217; &#8220;Virome&#8221; (n = 384) for further molecular analysis.</p></sec><sec id="sec2dot2-viruses-17-01243"><title>2.2. Ethics Statement</title><p>This research was approved by the Local Ethics Committee at the Federal Budgetary Institution of Science &#8220;Federal Scientific Research Institute of Viral Infections &#8216;Virome&#8217; Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Rospotrebnadzor&#8221; (Protocol N&#186; 1 dated 17 March 2022). Fecal samples were collected from medical institutions in the Sverdlovsk region: The Ekaterinburg Consultative Diagnostic Center and the State Autonomous Healthcare Institution of the Sverdlovsk region Children&#8217;s City Hospital (Kamensk-Uralsky). All patients gave their written consent to participate in the study, and patient data were stored anonymously and securely. All fecal samples were transported to the Federal Scientific Research Institute of Viral Infections &#8220;Virome&#8221; and stored at &#8722;20 &#176;C until analysis.</p></sec><sec id="sec2dot3-viruses-17-01243"><title>2.3. Isolation of RNA and PCR</title><p>A 10% suspension in physiological normal saline was prepared from fecal samples, vortexed, and clarified by centrifugation for 3 min at 10,000&#215; <italic toggle="yes">g</italic>. Nucleic acids were extracted using the Riboprep<sup>&#174;</sup> kit (Central Research Institute of Epidemiology, Moscow, Russian Federation). Subsequently, reverse transcription was performed to obtain cDNA from RNA templates using the REVERTA-L kit (Central Research Institute of Epidemiology, Moscow, Russian) according to the manufacturer&#8217;s protocol. Polymerase chain reaction (PCR) was set up using 5X ScreenMix-HS (EUROGEN, Moscow, Russian) reaction mix, deionized water, and a pair of specific oligonucleotide primers. The selected primer pair flanked a region of the norovirus genome spanning two genetic groups (GI, GII) corresponding to the ORF1/ORF2 region. For GI, the primer pair included MON432 (forward) and GISKR (reverse), while for GII, it comprised the primer pair MON431 (forward) and GIISKR (reverse) at a molar concentration of 20 [pmol/L] [<xref rid="B10-viruses-17-01243" ref-type="bibr">10</xref>]. Amplicon electrophoresis was performed on a 2% agarose gel (TBE buffer, 180 V, for 30 min). cDNA purification of the agarose gel was conducted using the Cleanup Standard reagent kit (EUROGEN, Moscow, Russia).</p></sec><sec id="sec2dot4-viruses-17-01243"><title>2.4. Sequencing a Fragment ORF1/ORF2 of the Norovirus Genome Using the Sanger Method</title><p>Target genome fragment amplification was followed by chain termination through the incorporation of dideoxynucleotides utilizing the BrilliantDyeTM Terminator (v3.1) Cycle Sequencing Kit, along with the BrilliantDye buffer and two pairs of oligonucleotide primers (GI&#8212;MON432/GISKR; GII&#8212;MON431/GIISKR at a molar concentration of 3.2 [pmol/L]) [<xref rid="B10-viruses-17-01243" ref-type="bibr">10</xref>]. Norovirus genome fragments were sequenced on the ABI 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) as previously described.</p></sec><sec id="sec2dot5-viruses-17-01243"><title>2.5. Preparation of NGS Libraries</title><p>Total RNA was extracted from fecal suspensions using the ExtractRNA kit (EUROGEN, Russia). cDNA synthesis followed by PCR was carried out using the RNAscribe RT Reverse Transcriptase kit (Biolabmix, Novosibirsk, Russia) and the BioMaster LR HS-PCR (2X) mix (Biolabmix, Russia), according to the laboratory protocol for the SMART-9N study [<xref rid="B11-viruses-17-01243" ref-type="bibr">11</xref>]. For enzymatic fragmentation and adapter ligation, we used the FTP Display and LIB Display kits (BioLink, Russia, Novosibirsk). cDNA purification was conducted with magnetic beads using VAHTS DNA Clean Beads (Vazyme, Nanjing, China).</p><p>To achieve greater HuNoV genome coverage using NGS, two panels of oligonucleotides were designed for the most prevalent genotypes in Russia: GII.4 (<xref rid="viruses-17-01243-t001" ref-type="table">Table 1</xref>) and GII.7 (<xref rid="viruses-17-01243-t002" ref-type="table">Table 2</xref>). The synthesized primers covered the norovirus genome fragments within 800 base pairs for the GII.4 genotype and 1000 base pairs for the GII.7 genotype. One-step RT-PCR was performed to amplify the target fragments of the full-length genome, using the Biolabmix-Premium kit (Biolabmix, Russia). Subsequent steps were executed according to the SMART-9N protocol [<xref rid="B11-viruses-17-01243" ref-type="bibr">11</xref>]. Amplified fragments were visualized on a 2% agarose gel (TBE buffer, 180 V for 30 min). Libraries prepared following the SMART-9N protocol and those obtained via enrichment methods were pooled into a single tube. The concentration of the final library pool was measured using a Qubit fluorometer (Thermo Fisher Scientific, Eugene, OR, USA) with the QubitTM dsDNA HS Assay Kit (Thermo Fisher Scientific, USA). Genomic libraries were sequenced on the Illumina MiSeq platform, utilizing the MiSeq Reagent Kit v2 for 300 cycles.</p></sec><sec id="sec2dot6-viruses-17-01243"><title>2.6. Bioinformatic and Phylogenetic Analysis of Nucleotide/Amino Acid Sequences from the ORF1/ORF2 Fragment Within the Norovirus Genome</title><p>Bioinformatic analysis of the identified nucleotide sequences from the ORF1/ORF2 fragment in the norovirus genome was conducted according to the algorithm established in our previously published study [<xref rid="B12-viruses-17-01243" ref-type="bibr">12</xref>]. Assembly of consensus sequences, generated from forward/reverse read typing results, was performed using UGENE software, version 52 [<xref rid="B13-viruses-17-01243" ref-type="bibr">13</xref>]. The number of consensus sequences included in the phylogenetic analysis was 6 for GII.7[P7] and 8 for GII.4[P16], with an average nucleotide fragment length of 490 bp. Genetic distance between amino acid sequences of norovirus genotypes was assessed using the p-distance matrix. We used the Neighbor-Joining method with the Kimura-2 parameter model for the reconstruction of additive phylograms and the calculation of pairwise distances among taxa in the GI and GII genogroups. Nucleotide sequences from the norovirus genome fragment generated in this study are deposited in GenBank, NCBI, with a total of n = 183 sequences under the following accession numbers: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP406492">PP406492</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP406500">PP406500</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP486238">PP486238</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP486248">PP486248</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ804494">PQ804494</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ804497">PQ804497</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP316687">PP316687</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP316695">PP316695</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP406485">PP406485</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP406491">PP406491</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780080.1">PQ780080.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780096">PQ780096</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780098">PQ780098</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ803147">PQ803147</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ803156">PQ803156</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ804488">PQ804488</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ804493">PQ804493</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596135">PQ596135</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596136">PQ596136</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596184">PQ596184</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596185">PQ596185</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614855">PQ614855</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614859">PQ614859</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614895">PQ614895</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614897">PQ614897</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614902">PQ614902</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ614903">PQ614903</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780062">PQ780062</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780063">PQ780063</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780076">PQ780076</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ780079">PQ780079</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596115">PQ596115</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596134">PQ596134</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP694327">PP694327</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596096">PQ596096</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596114">PQ596114</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104320">PV104320</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104325">PV104325</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104336">PV104336</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP658520">PP658520</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP694326">PP694326</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104293">PV104293</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104300">PV104300</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104308">PV104308</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104319">PV104319</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104210">PV104210</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104214">PV104214</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104278">PV104278</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104292">PV104292</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104188">PV104188</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104191">PV104191</ext-link>&#8212;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV104192">PV104192</ext-link>.</p></sec><sec id="sec2dot7-viruses-17-01243"><title>2.7. Bioinformatic and Phylogenetic Analysis of Full-Length Genome Sequences Belonging to Genotypes GII.4 and GII.7</title><p>Genome library construction for genotypes GII.4 and GII.7 utilized DRAGEN v. 4.3 algorithms (Sequencing Technology: Illumina). Resulting full-length genome nucleotide sequences were identified using the BLAST service (ver. 2.17.0) [<xref rid="B14-viruses-17-01243" ref-type="bibr">14</xref>]. Phylogenetic analysis employed the maximum likelihood method with the parametric Kimura-2 model. Genetic distance between complete amino acid sequences of norovirus genotypes was assessed using a p-distance matrix. Three-dimensional visualization of synonymous and nonsynonymous substitutions in peptide structures was conducted in the SWISS-MODEL client&#8211;server application [<xref rid="B15-viruses-17-01243" ref-type="bibr">15</xref>]. Nucleotide sequences of the full-length HuNoV genome generated in this study have been deposited in GenBank, NCBI. The total number of deposited sequences amounts to n = 8 under accession numbers <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746275.1">PV746275.1</ext-link>-<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746278.1">PV746278.1</ext-link> for GII.4[P16] and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746280.1">PV746280.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide-range" xlink:href="PV806172:PV806174">PV806172-PV806174</ext-link> for GII.7[P7].</p></sec></sec><sec sec-type="results" id="sec3-viruses-17-01243"><title>3. Results</title><sec id="sec3dot1-viruses-17-01243"><title>3.1. The Genotypic Composition of HuNoV Infection in the Sverdlovsk Region</title><p>During the studied period in 2024, the total number of analyzed fecal samples from patients with norovirus gastroenteritis confirmed by ELISA and/or real-time PCR amounted to n = 384. Following Sanger sequencing of the ORF1/ORF2 fragment in the HuNoV genome, n = 220 samples (57.3%) were successfully typed. The highest proportion of identified HuNoV strains corresponds to the second genetic group (GII&#8212;92%), while GI was less detected (8%). The detected HuNoV genotypic composition predominantly includes three capsid variants, GII.4, GII.7, and GII.17, along with their corresponding polymerase types, GII.P16, GII.P7, and GII.P17, respectively (<xref rid="viruses-17-01243-f003" ref-type="fig">Figure 3</xref>). The minor genotypic profile comprises capsid variants GII.3, GII.6, GII.2, GIV.1, GI.2, GI.7, and GI.6 and the following polymerase types: GII.P12, GII.P7, GI.P7, and GI.P2.</p><p>The HuNoV strains included in the NGS analysis were randomly chosen from the total pool of GII.4[P16] and GII.7[P7] genotypes identified in the Sverdlovsk region during 2024. For this random sample of n = 10, threshold cycle numbers were determined using real-time PCR (<xref rid="viruses-17-01243-t003" ref-type="table">Table 3</xref>). According to NGS results, eight full-lengths genome sequences corresponding to two of the most prevalent genotypes from the Sverdlovsk region, GII.4[P16] and GII.7[P7], were assembled. The median coverage for the NGS complete-genome nucleotide sequences, using the de novo approach, was 603 for GII.4[P16] and 246 for GII.7[P7].</p></sec><sec id="sec3dot2-viruses-17-01243"><title>3.2. Phylogenetic Analysis of Nucleotide Sequences from the ORF1/ORF2 Fragment in the HuNoV Genome for the Most Prevalent GII.4 and GII.7 Strains Identified in the Sverdlovsk Region in 2024</title><p>When analyzing the additive phylogram with the identified strain GII.4[P16] (<xref rid="viruses-17-01243-f003" ref-type="fig">Figure 3</xref>), a common internal node form indicated close phylogenetic relationships among the sequences. In 2024, the overwhelming majority of nucleotide sequences from the capsid and polymerase type GII.4[P16] underwent no significant evolutionary changes in the RNA polypeptide chain. Despite a relatively genetically homogeneous sample of GII.4[P16] strains from the Sverdlovsk region, some distinct internal clades with the most divergent strains, such as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP406489.1">PP406489.1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ804497.1">PQ804497.1</ext-link>, emerge. The percentage values for genetic distance in these highly heterogeneous strains compared to adjacent GII.4[P16] strains from other municipalities in the Sverdlovsk region ranged from 8% to 12%. Other GII.4[P16] strains that presented in the municipalities exhibited percentage identity values ranging from 96% to 100%.</p><p>In the same additive phylogram (<xref rid="viruses-17-01243-f004" ref-type="fig">Figure 4</xref>), the cluster of the Sverdlovsk strain GII.7[P7] forms paraphyletic ties with strains from Nizhny Novgorod (Russian Federation) and Japan and shows the lowest genetic distance of 1% to 3%. The formation of distinct internal nodes is recorded for strains <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PP486245.1">PP486245.1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ596106.1">PQ596106.1</ext-link>. The matrix for genetic distances in amino acid sequences among the most divergent GII.7[P7] strains shows a 15% distance compared to other 2024 GII.7[P7] genovariants identified in our region.</p></sec><sec id="sec3dot3-viruses-17-01243"><title>3.3. Phylogenetic Analysis of Nucleotide Sequences from Full-Length Genomes of Norovirus Capsid Variants GII.4 and GII.7</title><p>Concerning the reconstruction of HuNoV GII.4 phylogenetic events for nucleotide sequences from full-length genomes, the topology of the cladogram demonstrates the formation of two distinct nodes with clusters of GII.4 strains from the Sverdlovsk region. (<xref rid="viruses-17-01243-f005" ref-type="fig">Figure 5</xref>). One cluster, including strains <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746277.1">PV746277.1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746276.1">PV746276.1</ext-link>, forms polyphyletic relationships with GII.4 strains from Nizhny Novgorod, the USA, and India. Another cluster, consisting of strains <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746275.1">PV746275.1</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746278.1">PV746278.1</ext-link>, establishes polyphyletic connections with a cluster of strains from the USA and Japan.</p><p>Concerning the reconstruction of the additive phylogram, a formation of terminal nodes with varying rates of evolutionary events for clusters of GII.4 strains from the Sverdlovsk region is recorded (<xref rid="viruses-17-01243-f006" ref-type="fig">Figure 6</xref>). When constructing a matrix of genetic distances for amino acid sequences from these GII.4 strains, low levels of divergence were observed, ranging from 1 to 2%. The genetic distance between GII.4 strains from the Sverdlovsk region and strains from other regions in Russia, as well as from other countries, varied between 3% and 5%.</p><p>Phylogenetic reconstruction, involving nucleotide sequences from full-length genomes of GII.7[P7] noroviruses, shows the formation of an internal clade with a hypothetical common ancestor among GII.7[P7] strains from the Sverdlovsk region and Nizhny Novgorod (<xref rid="viruses-17-01243-f007" ref-type="fig">Figure 7</xref>). These GII.7[P7] strains, forming a common cluster with sequences from Nizhny Novgorod, also exhibit polyphyletic relationships with sequences from Japan. The genetic distance for amino acid sequences from these strains to current sequences from Nizhny Novgorod and Japan identified during the post-COVID-19 period is 1&#8211;2%. The genetic distance for amino acid sequences from strains in the Sverdlovsk region to GII.7[P7] sequences found during the pre-COVID-19 period varies between 16 and 18%. Analysis of the cladogram topology reveals the formation of a distinct internal clade with a terminal node at strain <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746280.1">PV746280.1</ext-link>. When constructing a genetic distance matrix, strain <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746280.1">PV746280.1</ext-link> demonstrates the highest genetic distance for amino acid sequences relative to adjacent GII.7[P7] strains from the Sverdlovsk region, with a divergence percentage ranging from 24 to 35%.</p></sec><sec id="sec3dot4-viruses-17-01243"><title>3.4. Three-Dimensional Models of the Major Capsid Protein VP1 from GII.4 and GII.7 HuNoVs</title><p>Three-dimensional modeling of the structural protein VP1 in GII.4 norovirus strains revealed several non-synonymous substitutions at sites within amino acid sequences encoding antigenic determinants responsible for receptor-mediated endocytosis into target cells (<xref rid="viruses-17-01243-f008" ref-type="fig">Figure 8</xref>). In the identified GII.4[P16] strains, amino acid substitutions were found at site H (His) [site 297] =&gt; R (Arg) and N (Asn) [site 372] =&gt; D (Asp), which are part of epitope A, critical in the conformational integrity of the major capsid protein VP1. Additionally, the identified amino acid substitutions H (His) [site 297] =&gt; R (Arg), N (Asn) [site 372] =&gt; D (Asp), and V (Val) [site 317] =&gt; I (Ile) are located within the region encoding the P2 subdomain of the major capsid protein VP1, essential for viral penetration into target cells. The amino acid substitution at site V (Val) [site 47] =&gt; I (Ile) positioned in the domain N/S plays a role in the formation of the VP1 shell. Full-length reference genomes from GenBank used to determine non-synonymous amino acid substitutions in GII.4[P16] strains from the Sverdlovsk region include <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ214835.1">PQ214835.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ195931.1">PQ195931.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP901694.1">OP901694.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="OP712198.1">OP712198.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MW305632.1">MW305632.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MK762568.1">MK762568.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MK756038.1">MK756038.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MG892929.3">MG892929.3</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC790068.1">LC790068.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC790061.1">LC790061.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC777250.1">LC777250.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC769714.1">LC769714.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC769708.1">LC769708.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC769691.1">LC769691.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC175468.1">LC175468.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KY947550.1">KY947550.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KY947549.1">KY947549.1</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KY887604.1">KY887604.1</ext-link>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="KY887601.1">KY887601.1</ext-link>.</p><p>Similarly, the analysis of 3D modeling results for structural protein VP1 from GII.7 norovirus strains shows two identical non-synonymous amino acid substitutions in two GII.7[P7] norovirus strains (<xref rid="viruses-17-01243-f009" ref-type="fig">Figure 9</xref>). The strain <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV806172.1">PV806172.1</ext-link> exhibited a substitution at the site encoding the P1 domain in region D of the VP1 structural protein&#8212;M (Met) [site 237] =&gt; K (Lys); the strain <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV806173.1">PV806173.1</ext-link> showed a substitution at the site encoding the VP1 capsid shell&#8212;G (Gly) [site 171] =&gt; S (Ser). Full-length reference genomes from GenBank used to identify non-synonymous amino acid substitutions in GII.7[P7] strains from the Sverdlovsk region include <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ100947.1">PQ100947.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ100948.1">PQ100948.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC877021.1">LC877021.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC877023.1">LC877023.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ100946.1">PQ100946.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC877024.1">LC877024.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ507186.1">PQ507186.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC877026.1">LC877026.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PQ594187.1">PQ594187.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC877033.1">LC877033.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MW305550.1">MW305550.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MW305606.1">MW305606.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MW305602.1">MW305602.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MZ292759.1">MZ292759.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC122887.1">LC122887.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="LC122889.1">LC122889.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MW284778.1">MW284778.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MF140647.1">MF140647.1</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MT731332.1">MT731332.1</ext-link>; and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="MK762722.1">MK762722.1</ext-link>.</p></sec></sec><sec sec-type="discussion" id="sec4-viruses-17-01243"><title>4. Discussion</title><p>This study focused on analyzing the molecular&#8211;genotypic composition of HuNoV pathogens identified in the Sverdlovsk region in 2024. It demonstrated that the genetic diversity among noroviruses falls into two genetic groups (GI and GII), and it examined the circulation patterns of identified genovariants along with evolutionary events within various genovariants. HuNoV genotyping results, obtained through Sanger sequencing targeting the ORF1/ORF2 fragments in the norovirus genome, reveal a trend toward an increase in confirmed cases of GII genogroup HuNoV AGE in 2024. This trend aligns with global patterns in genetic group circulation, where noroviruses from the GII genogroup dominated both pediatric and adult populations [<xref rid="B16-viruses-17-01243" ref-type="bibr">16</xref>]. The results also demonstrate the emergence of two genotypic profiles: a major genotypic profile and a minor genotypic profile. The major genotypic profile primarily includes GII.4[P16], GII.7[P7], and GII.17[P17]. A significant distinction to the major genotypic profile in 2024, compared to previous analytical periods, is the increasing number of cases linked to the emerging recombinant genovariant GII.7[P7]. This latter has displaced the previously dominant GII.7[P17] [<xref rid="B17-viruses-17-01243" ref-type="bibr">17</xref>], which actively circulated from 2022 to 2023 [<xref rid="B12-viruses-17-01243" ref-type="bibr">12</xref>]. The higher incidence of GII.4[P16] noroviruses correlates with results from studies conducted in various countries, where GII.4[P16] emerges as the most frequently encountered genovariant in HuNoV gastroenteritis cases [<xref rid="B5-viruses-17-01243" ref-type="bibr">5</xref>,<xref rid="B12-viruses-17-01243" ref-type="bibr">12</xref>,<xref rid="B18-viruses-17-01243" ref-type="bibr">18</xref>,<xref rid="B19-viruses-17-01243" ref-type="bibr">19</xref>]. Conversely, reports regarding the widespread presence of recombinant GII.7[P7] remain absent, except in certain regions in Russia and Japan, suggesting the unique nature of the major HuNoV landscape identified in the Sverdlovsk region in 2024. Over the studied period, other registered HuNoV strains from genogroups GI and GII included types GII.3[P12], GII.6[P7], GII.2[Px], GIV.1[Px], GI.6[P11], GI.7[P7], and GI.2[P2]. The 2024 genotype distribution of HuNoVs in the minor genotypic profile further confirms the uniqueness of the recorded genotypic structure in the Sverdlovsk region for the analytical period.</p><p>Phylogenetic analysis results for the ORF1/ORF2 fragment from the HuNoV genome reveal paraphyletic connections among strains originating from Japan, Brazil, the USA, Spain, and other countries for the two most common genotypes GII.4[P16] and GII.7[P7]. The increased number of amino acid sequences for GII.4[P16] found in this study demonstrates minimal genetic distance from non-Russian strains, ranging from 98% to 100% identity, indicating the widespread dissemination of GII.4[P16] genotypes. In interpreting phylogenetic events related to GII.7[P7], clustering occurs with sequences from Japan and Nizhny Novgorod, exhibiting an identity degree of 98% to 100%. The high percentage of homology within the analyzed segment of the norovirus genome indirectly might suggest the potential importation of recombinant GII.7[P7] from Japan into Russian territory.</p><p>Phylogenetic analysis of HuNoV full-length genomes GII.4[P16] and GII.7[P7] shows similar results to those identified in phylogenetic analysis of ORF1/OFR2 sequences. HuNoV full-length phylogenetic analysis for GII.4[P16] indicates the formation of the smallest genetic distance between strains from the Sverdlovsk region and non-Russian GII.4[P16] strains, showing 95% to 97% identity. A more detailed examination of amino acid sequences from GII.4[P16] strains in the Sverdlovsk region revealed several mutational substitutions, possibly driven by forces of divergent evolution and geographical features influencing circulation. A high percentage of identity between Sverdlovsk strains and non-Russian strains supports evidence of the GII.4[P16] genovariant&#8217;s widespread circulation. Phylogenetic analysis results for GII.7[P7] indicate a high degree of homology with strains from Nizhny Novgorod and Japan, with the identity percentage reaching 98&#8211;99%. It is important to note that the smallest genetic distance with Sverdlovsk strains is observed in non-Russian strains identified during the post-COVID-19 period from 2022 to 2024. A comparison of genetic distances in amino acid sequences between Sverdlovsk strains and non-Russian strains identified in the pre-COVID-19 period shows an increase in divergence percentages, reaching 16&#8211;18%. The strain GII.7[P7] <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746280.1">PV746280.1</ext-link> forms a distinct internal clade, whereas divergence among other Sverdlovsk strains varies between 24 and 35%. The largest genetic distance between Sverdlovsk GII.7[P7] strains and strains originating from other countries developed during the studied evolutionary events may result from driving forces behind divergent evolution through reproductive isolation processes following multiple passages of recombinant GII.7[P7] in the human population [<xref rid="B20-viruses-17-01243" ref-type="bibr">20</xref>,<xref rid="B21-viruses-17-01243" ref-type="bibr">21</xref>].</p><p>Analysis of results from 3D models examining nonsynonymous amino acid substitutions in key antigenic determinants of the main capsid protein VP1 revealed several mutational changes in genovariants GII.4[P16] and GII.7[P7]. In the sequenced Sverdlovsk GII.4[P16] strains, approximately four significant mutations appeared that do not occur in other non-Russian strains, including some Russian strains identified in 2022. A greater number of mutational changes in Sverdlovsk GII.4[P16] strains impact amino acid sites in region D of the VP1 capsid protein, responsible for receptor-mediated endocytosis into target cells [<xref rid="B22-viruses-17-01243" ref-type="bibr">22</xref>,<xref rid="B23-viruses-17-01243" ref-type="bibr">23</xref>]. Closer monitoring of evolutionary events in region D of the VP1 capsid protein will enable predictions regarding the emergence of group illness outbreaks within the human population, particularly where collective immunity is lacking [<xref rid="B24-viruses-17-01243" ref-type="bibr">24</xref>]. The identified amino acid substitutions are of critical importance due to their role in evading the adaptive immune response in the human body [<xref rid="B23-viruses-17-01243" ref-type="bibr">23</xref>]. The further evolution of established antigenic patterns in binding subdomains will inevitably lead to an increased incidence of HuNoV gastroenteritis. In GII.7[P7] strains from the Sverdlovsk region, only two mutational changes affected amino acid sites responsible for forming the structural protein VP1 shell and the P1 subdomain, both essential for the penetration process into target cells. The high identity of polypeptides among Sverdlovsk GII.7[P7] strains and those from Japan, combined with the absence of significant mutational changes in GII.7[P7] strains in this study, suggests a possible introduction of recombinant GII.7[P7] from Japan into Russian territory, as previously mentioned in ORF1/ORF2 fragment phylogenetic analysis.</p><p>One of the main limitations in HuNoV genotyping is the choice of method. Different laboratories may use varying methods and protocols, leading to significant differences in results and reducing the overall reliability and comparability of genotyping data. The main limitation in our study is the number of norovirus strains included in the NGS analysis. We chose five GII.4 strains and five GII.7 strains, as the most prevalent and representative HuNoV genotypes in our region. We could not include more HuNoV strains due to financial limitations and the need to achieve better genome coverage using NGS. For the same reasons, we did not include the less prevalent circulating genotypes despite the vast diversity of HuNoV genotypes in our results.</p></sec><sec sec-type="conclusions" id="sec5-viruses-17-01243"><title>5. Conclusions</title><p>Thus, as a result of the molecular characterization and the epidemiology of HuNoV circulating in the Sverdlovsk region, relevant data emerged regarding the genotypic composition of HuNoVs, circulation characteristics, and evolutionary events involving the most common genovariants GII.4[P16] and GII.7[P7]. The presented genotyping system, based on the analysis of the ORF1/ORF2 fragment in the norovirus genome, proves most suitable for routine molecular&#8211;genetic monitoring, aiming for continuous updates to the norovirus landscape in the Sverdlovsk region. Studying mutational changes in key antigenic determinants defining interaction specificity with the human host will allow predictions regarding evolutionary developments, to control the epidemiological situation within surveillance systems and to mitigate the impact of emerging HuNoV strains.</p></sec></body><back><ack><title>Acknowledgments</title><p>We express our sincere gratitude to the entire scientific team of the Genomics and Evolution of Viruses Laboratory at the Research Institute of Virology, Federal State Budgetary Scientific Institution Federal Research Center for Fundamental and Translational Medicine, for their invaluable support throughout the research process. We thank The Ekaterinburg Consultative Diagnostic Center and the State Autonomous Healthcare Institution of the Sverdlovsk region Children&#8217;s City Hospital (Kamensk-Uralsky) for providing native biological material from patients.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, conducting the research, analysis of research results, writing and preparation of the original text: R.B.; conceptualization, writing, reviewing and editing, validation: T.I.; conducting the research, analysis of research results: D.P.; project administration, conducting the research: O.O.; conducting the research, analysis of research results: A.M.; conducting the research, analysis of research results: M.S.; conceptualization, author oversight, and funding: A.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This research has obtained approval from the Local Ethics Committee at the Federal Budgetary Institution of Science &#8220;Federal Scientific Research Institute of Viral Infections &#8216;Virome&#8217; Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Rospotrebnadzor&#8221; (Protocol &#8470; 1 dated 03.17.2022).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in this study.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-17-01243"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graziano</surname><given-names>V.R.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wilen</surname><given-names>C.B.</given-names></name></person-group><article-title>Norovirus Attachment and Entry</article-title><source>Viruses</source><year>2019</year><volume>11</volume><elocation-id>495</elocation-id><pub-id pub-id-type="doi">10.3390/v11060495</pub-id><pub-id pub-id-type="pmid">31151248</pub-id><pub-id pub-id-type="pmcid">PMC6630345</pub-id></element-citation></ref><ref id="B2-viruses-17-01243"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopman</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Steele</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kirkwood</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Parashar</surname><given-names>U.D.</given-names></name></person-group><article-title>The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control</article-title><source>PLoS Med.</source><year>2016</year><volume>13</volume><elocation-id>e1001999</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1001999</pub-id><pub-id pub-id-type="pmid">27115709</pub-id><pub-id pub-id-type="pmcid">PMC4846155</pub-id></element-citation></ref><ref id="B3-viruses-17-01243"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlson</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Dilley</surname><given-names>A.</given-names></name><name name-style="western"><surname>O&#8217;Grady</surname><given-names>T.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lopman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Viscidi</surname><given-names>E.</given-names></name></person-group><article-title>A Narrative Review of Norovirus Epidemiology, Biology, and Challenges to Vaccine Development</article-title><source>npj Vaccines</source><year>2024</year><volume>9</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.1038/s41541-024-00884-2</pub-id><pub-id pub-id-type="pmid">38811605</pub-id><pub-id pub-id-type="pmcid">PMC11137017</pub-id></element-citation></ref><ref id="B4-viruses-17-01243"><label>4.</label><element-citation publication-type="webpage"><article-title>State Report by Rospotrebnadzor &#171;Sanitary and Epidemiological Well-Being in the Russian Federation in 2024&#8211;Moscow&#187;, 21 May 2025</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.rospotrebnadzor.ru/upload/iblock/b8a/u6lsxjabw032jkdf837nlaezxu3ue09m/GD_SEB.pdf" ext-link-type="uri">https://www.rospotrebnadzor.ru/upload/iblock/b8a/u6lsxjabw032jkdf837nlaezxu3ue09m/GD_SEB.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-20">(accessed on 20 May 2025)</date-in-citation></element-citation></ref><ref id="B5-viruses-17-01243"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tohma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lepore</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Degiuseppe</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Khamrin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mayta</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nwaba</surname><given-names>A.U.A.</given-names></name><name name-style="western"><surname>Ford-Siltz</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Green</surname><given-names>K.Y.</given-names></name><etal/></person-group><article-title>Genome-wide analyses of human noroviruses provide insights on evolutionary dynamics and evidence of coexisting viral populations evolving under recombination constraints</article-title><source>PLoS Pathog.</source><year>2021</year><volume>17</volume><elocation-id>e1009744</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009744</pub-id><pub-id pub-id-type="pmid">34255807</pub-id><pub-id pub-id-type="pmcid">PMC8318288</pub-id></element-citation></ref><ref id="B6-viruses-17-01243"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McSweeney</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Young</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>V.K.</given-names></name></person-group><article-title>Norovirus VPg Binds RNA through a Conserved N-Terminal K/R Basic Patch</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>1282</elocation-id><pub-id pub-id-type="doi">10.3390/v13071282</pub-id><pub-id pub-id-type="pmid">34209211</pub-id><pub-id pub-id-type="pmcid">PMC8310136</pub-id></element-citation></ref><ref id="B7-viruses-17-01243"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad</surname><given-names>B.V.V.</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Dokland</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bella</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rossmann</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Estes</surname><given-names>M.K.</given-names></name></person-group><article-title>X-Ray Crystallographic Structure of the Norwalk Virus Capsid</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>287</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1126/science.286.5438.287</pub-id><pub-id pub-id-type="pmid">10514371</pub-id></element-citation></ref><ref id="B8-viruses-17-01243"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinj&#233;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hamidjaja</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Sobsey</surname><given-names>M.D.</given-names></name></person-group><article-title>Development and Application of a Capsid VP1 (Region D) Based Reverse Transcription PCR Assay for Genotyping of Genogroup I and II Noroviruses</article-title><source>J. Virol. Methods</source><year>2004</year><volume>116</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2003.11.001</pub-id><pub-id pub-id-type="pmid">14738976</pub-id></element-citation></ref><ref id="B9-viruses-17-01243"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vakulenko</surname><given-names>Y.A.</given-names></name><name name-style="western"><surname>Orlov</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Lukashev</surname><given-names>A.N.</given-names></name></person-group><article-title>Patterns and Temporal Dynamics of Natural Recombination in Noroviruses</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>372</elocation-id><pub-id pub-id-type="doi">10.3390/v15020372</pub-id><pub-id pub-id-type="pmid">36851586</pub-id><pub-id pub-id-type="pmcid">PMC9961210</pub-id></element-citation></ref><ref id="B10-viruses-17-01243"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navarro-Lle&#243;</surname><given-names>N.</given-names></name><name name-style="western"><surname>Santiso-Bell&#243;n</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vila-Vicent</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carmona-Vicente</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gozalbo-Rovira</surname><given-names>R.</given-names></name><name name-style="western"><surname>C&#225;rcamo-Calvo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-D&#237;az</surname><given-names>J.</given-names></name><name name-style="western"><surname>Buesa</surname><given-names>J.</given-names></name></person-group><article-title>Recombinant Noroviruses Circulating in Spain from 2016 to 2020 and Proposal of Two Novel Genotypes within Genogroup I</article-title><source>Microbiol. Spectr.</source><year>2022</year><volume>10</volume><fpage>e02505-21</fpage><pub-id pub-id-type="doi">10.1128/spectrum.02505-21</pub-id><pub-id pub-id-type="pmid">35862999</pub-id><pub-id pub-id-type="pmcid">PMC9430863</pub-id></element-citation></ref><ref id="B11-viruses-17-01243"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claro</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Ramundo</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Coletti</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>C.A.M.</given-names></name><name name-style="western"><surname>Valenca</surname><given-names>I.N.</given-names></name><name name-style="western"><surname>Candido</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Sales</surname><given-names>F.C.S.</given-names></name><name name-style="western"><surname>Manuli</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>de Jesus</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>de Paula</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Rapid Viral Metagenomics Using SMART-9N Amplification and Nanopore Sequencing</article-title><source>Wellcome Open Res.</source><year>2023</year><volume>6</volume><fpage>241</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.17170.2</pub-id><pub-id pub-id-type="pmid">37224315</pub-id><pub-id pub-id-type="pmcid">PMC10189296</pub-id></element-citation></ref><ref id="B12-viruses-17-01243"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bykov</surname><given-names>R.</given-names></name><name name-style="western"><surname>Itani</surname><given-names>T.</given-names></name><name name-style="western"><surname>Starikova</surname><given-names>P.</given-names></name><name name-style="western"><surname>Skryabina</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kilyachina</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koltunov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Romanov</surname><given-names>S.</given-names></name><name name-style="western"><surname>Semenov</surname><given-names>A.</given-names></name></person-group><article-title>Genetic Diversity and Phylogenetic Relationship of Human Norovirus Sequences Derived from Municipalities within the Sverdlovsk Region of Russia</article-title><source>Viruses</source><year>2024</year><volume>16</volume><elocation-id>1001</elocation-id><pub-id pub-id-type="doi">10.3390/v16071001</pub-id><pub-id pub-id-type="pmid">39066164</pub-id><pub-id pub-id-type="pmcid">PMC11281373</pub-id></element-citation></ref><ref id="B13-viruses-17-01243"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>R.</given-names></name><name name-style="western"><surname>Golosova</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sukhomlinov</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tiunov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Prosperi</surname><given-names>M.</given-names></name></person-group><article-title>Flexible Design of Multiple Metagenomics Classification Pipelines with UGENE</article-title><source>Bioinformatics</source><year>2019</year><volume>35</volume><fpage>1963</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty901</pub-id><pub-id pub-id-type="pmid">30358807</pub-id></element-citation></ref><ref id="B14-viruses-17-01243"><label>14.</label><element-citation publication-type="gov"><article-title>National Center for Biotechnology Information, Basic Local Alignment Search Tool</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" ext-link-type="uri">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-20">(accessed on 20 May 2025)</date-in-citation></element-citation></ref><ref id="B15-viruses-17-01243"><label>15.</label><element-citation publication-type="webpage"><article-title>SWISS-MODEL Client-Server Application</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://swissmodel.expasy.org/" ext-link-type="uri">https://swissmodel.expasy.org/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-20">(accessed on 20 May 2025)</date-in-citation></element-citation></ref><ref id="B16-viruses-17-01243"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoa Tran</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Trainor</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nakagomi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cunliffe</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Nakagomi</surname><given-names>O.</given-names></name></person-group><article-title>Molecular Epidemiology of Noroviruses Associated with Acute Sporadic Gastroenteritis in Children: Global Distribution of Genogroups, Genotypes and GII.4 Variants</article-title><source>J. Clin. Virol.</source><year>2013</year><volume>56</volume><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2012.11.011</pub-id><pub-id pub-id-type="pmid">23218993</pub-id></element-citation></ref><ref id="B17-viruses-17-01243"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Graaf</surname><given-names>M.</given-names></name><name name-style="western"><surname>van Beek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vennema</surname><given-names>H.</given-names></name><name name-style="western"><surname>Podkolzin</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Hewitt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bucardo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Templeton</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mans</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nordgren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Reuter</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Emergence of a Novel GII.17 Norovirus&#8212;End of the GII.4 Era?</article-title><source>Eurosurveillance</source><year>2015</year><volume>20</volume><fpage>21178</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES2015.20.26.21178</pub-id><pub-id pub-id-type="pmid">26159308</pub-id><pub-id pub-id-type="pmcid">PMC5921880</pub-id></element-citation></ref><ref id="B18-viruses-17-01243"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khamrin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kumthip</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yodmeeklin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jampanil</surname><given-names>N.</given-names></name><name name-style="western"><surname>Phengma</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yamsakul</surname><given-names>P.</given-names></name><name name-style="western"><surname>Okitsu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ushijima</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maneekarn</surname><given-names>N.</given-names></name></person-group><article-title>Changing Predominance of Norovirus Recombinant Strains GII.2[P16] to GII.4[P16] and GII.4[P31] in Thailand, 2017 to 2018</article-title><source>Microbiol. Spectr.</source><year>2022</year><volume>10</volume><fpage>e00448-22</fpage><pub-id pub-id-type="doi">10.1128/spectrum.00448-22</pub-id><pub-id pub-id-type="pmid">35546545</pub-id><pub-id pub-id-type="pmcid">PMC9241750</pub-id></element-citation></ref><ref id="B19-viruses-17-01243"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parra</surname><given-names>G.I.</given-names></name></person-group><article-title>Emergence of Norovirus Strains: A Tale of Two Genes</article-title><source>Virus Evol.</source><year>2019</year><volume>5</volume><fpage>vez048</fpage><pub-id pub-id-type="doi">10.1093/ve/vez048</pub-id><pub-id pub-id-type="pmid">32161666</pub-id><pub-id pub-id-type="pmcid">PMC6875644</pub-id></element-citation></ref><ref id="B20-viruses-17-01243"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Should We Pay Attention to Recombinant Norovirus Strain GII. P7/GII. 6?</article-title><source>J. Infect. Public Health</source><year>2019</year><volume>12</volume><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2018.12.007</pub-id><pub-id pub-id-type="pmid">30658905</pub-id></element-citation></ref><ref id="B21-viruses-17-01243"><label>21.</label><element-citation publication-type="webpage"><article-title>Molecular Evolutionary Analyses of the RNA-Dependent RNA Polymerase (RdRp) Region and VP1 Gene in Human Norovirus Genotypes GII.P6-GII.6 and GII.P7-GII.6</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/1999-4915/15/7/1497" ext-link-type="uri">https://www.mdpi.com/1999-4915/15/7/1497</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-04-10">(accessed on 10 April 2025)</date-in-citation><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v15071497</pub-id><pub-id pub-id-type="pmcid">PMC10383674</pub-id><pub-id pub-id-type="pmid">37515184</pub-id></element-citation></ref><ref id="B22-viruses-17-01243"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarado</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ettayebi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Atmar</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Bombardi</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Kose</surname><given-names>N.</given-names></name><name name-style="western"><surname>Estes</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Crowe</surname><given-names>J.E.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Human Monoclonal Antibodies That Neutralize Pandemic GII. 4 Noroviruses</article-title><source>Gastroenterology</source><year>2018</year><volume>155</volume><fpage>1898</fpage><lpage>1907</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.039</pub-id><pub-id pub-id-type="pmid">30170116</pub-id><pub-id pub-id-type="pmcid">PMC6402321</pub-id></element-citation></ref><ref id="B23-viruses-17-01243"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolawole</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>H.Q.</given-names></name><name name-style="western"><surname>Svoboda</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Pettitt</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Wobus</surname><given-names>C.E.</given-names></name></person-group><article-title>Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms</article-title><source>mSphere</source><year>2017</year><volume>2</volume><fpage>e00334-17</fpage><pub-id pub-id-type="doi">10.1128/mSphere.00334-17</pub-id><pub-id pub-id-type="pmid">29062895</pub-id><pub-id pub-id-type="pmcid">PMC5646240</pub-id></element-citation></ref><ref id="B24-viruses-17-01243"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ford-Siltz</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Wales</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tohma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Parra</surname><given-names>G.I.</given-names></name></person-group><article-title>Genotype-Specific Neutralization of Norovirus Is Mediated by Antibodies Against the Protruding Domain of the Major Capsid Protein</article-title><source>J. Infect. Dis.</source><year>2022</year><volume>225</volume><fpage>1205</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa116</pub-id><pub-id pub-id-type="pmid">32179892</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-17-01243-f001" orientation="portrait"><label>Figure 1</label><caption><p>Illustration of the main capsid protein structure&#8212;VP1 in the norovirus virion. (The image was created using BioRender web application).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g001.jpg"/></fig><fig position="float" id="viruses-17-01243-f002" orientation="portrait"><label>Figure 2</label><caption><p>Municipalities of the Sverdlovsk region participating in this study (1&#8212;Ekaterinburg, 2&#8212;Kamensk-Uralsky, 3&#8212;Nizhny Tagil, 4&#8212;Sukhoy Log).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g002.jpg"/></fig><fig position="float" id="viruses-17-01243-f003" orientation="portrait"><label>Figure 3</label><caption><p>Genotypic composition of HuNoVs identified in the Sverdlovsk region during the analytical period of 2024 (GII.Px&#8212;unidentified polymerase types).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g003.jpg"/></fig><fig position="float" id="viruses-17-01243-f004" orientation="portrait"><label>Figure 4</label><caption><p>Reconstruction of phylogenetic events for nucleotide sequences from the VP1/RdRp fragment of genovariants GII.4[P16] and GII.7[P7] in 2024, using the Kimura 2-parameter model. Black squares represent genovariant GII.4[P16], and black triangles represent genovariant GII.7[P7], identified in the Sverdlovsk region in 2024.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g004.jpg"/></fig><fig position="float" id="viruses-17-01243-f005" orientation="portrait"><label>Figure 5</label><caption><p>Cladogram of nucleotide sequences from full-length genomes of GII.4 noroviruses (the black square indicates full-length genome sequences of GII.4 norovirus strains identified in the Sverdlovsk region in 2024; the black circle represents full-length genome sequences of GII.4 norovirus strains identified in other regions of Russia over various analytical periods).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g005.jpg"/></fig><fig position="float" id="viruses-17-01243-f006" orientation="portrait"><label>Figure 6</label><caption><p>Additive phylogram of nucleotide sequences from full-length genomes of GII.4 noroviruses (the black square indicates full-length genome sequences of GII.4 norovirus strains identified in the Sverdlovsk region in 2024; the black circle represents full-length genome sequences of GII.4 norovirus strains identified in other regions of Russia over various analytical periods).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g006.jpg"/></fig><fig position="float" id="viruses-17-01243-f007" orientation="portrait"><label>Figure 7</label><caption><p>Cladogram of nucleotide sequences from full-length genomes for GII.7 noroviruses (black square indicates full-length genome sequences for GII.7 norovirus strains identified in the Sverdlovsk region in 2024; black circle indicates full-length genome sequences for GII.7 norovirus strains identified in other regions of Russia during 2024).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g007.jpg"/></fig><fig position="float" id="viruses-17-01243-f008" orientation="portrait"><label>Figure 8</label><caption><p>Reconstruction of 3D models showing non-synonymous substitutions in amino acid sequences for the main structural protein VP1 from GII.4 norovirus strains in the Sverdlovsk region. (<bold>a</bold>) Non-synonymous substitutions in VP1 protein from strain RU/SVE/GII.4[P16]/2/2024; (<bold>b</bold>) non-synonymous substitutions in VP1 protein from strain RU/SVE/GII4[P16]/4/2024; (<bold>c</bold>) non-synonymous substitutions in VP1 protein from strain RU/SVE/GII.4[P16]/1630/2024; (<bold>d</bold>) non-synonymous substitutions in VP1 protein from strain RU/SVE/GII.4[P16]/1987/2024) (3D visualization illustrating synonymous/non-synonymous substitutions in peptide structures was created using the SWISS-MODEL client&#8211;server application).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g008.jpg"/></fig><fig position="float" id="viruses-17-01243-f009" orientation="portrait"><label>Figure 9</label><caption><p>Reconstruction of 3D models showing non-synonymous substitutions in amino acid sequences for the main structural protein VP1 from GII.7 norovirus strains in the Sverdlovsk region. (<bold>a</bold>) Non-synonymous substitutions in the VP1 protein from strain RU/SVE/GII.7[P7]/28/2024; (<bold>b</bold>) non-synonymous substitutions in the VP1 protein from strain RU/SVE/GII.7[P7]/30/2024) (3D visualization illustrating synonymous and non-synonymous substitutions in peptide structures utilized the SWISS-MODEL client&#8211;server application).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="viruses-17-01243-g009.jpg"/></fig><table-wrap position="float" id="viruses-17-01243-t001" orientation="portrait"><object-id pub-id-type="pii">viruses-17-01243-t001_Table 1</object-id><label>Table 1</label><caption><p>Oligonucleotide panel for GII.4 genotyping (average fragment length, 800 bp).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer Region</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tm Hybridization</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_1F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GTGAATGAAGATGGCGTCTAACGA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_1R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAGGTCTTTTATGGGYCTGGTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">807&#8211;830</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_2F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTGCTGGGTGTTAGACCTCA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">635&#8211;656</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_2R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCTGGCYGCTGCTATTCGAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1406&#8211;1426</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_3F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCACATGACAACCCTGTTGAAAGA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1266&#8211;1290</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_3R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CACGGGCAATCAGAGAACCG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2027&#8211;2047</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_4F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GGTCAGCCAGATATGTGGAAGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1893&#8211;1915</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_4R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTYAAGCCCTTGCTGGAGAATG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2668&#8211;2691</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_5F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTCTGGTCGAAGCCACAATYAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2513&#8211;2536</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_5R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GTTCCCATTCTGGCTGCAAGAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3307&#8211;3329</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_6F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCCGRTTCAGRTTCCCAARACCAATT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3195&#8211;3220</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_6R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAYGAGATGAAGGCACACTGCATA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4181&#8211;4204</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_7F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GGCAARCCTCCAAGACCAAGTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3786&#8211;3808</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_7R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GGAATTTGCTTGTATAATGTCAGGGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4546&#8211;4572</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_8F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGTCGCTGAGGATCTRCTGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4393&#8211;4412</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_8R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTATTGCGGCACCTGTAGCG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5191&#8211;5210</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_9F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTGACTTGAGCACGTGGGAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5034&#8211;5053</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_9R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCCCAGCAGTGCMTTTGTTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5840&#8211;5859</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_10F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GATGATGTTTTCACAGTYTCGTGCC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5661&#8211;5685</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_10R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GGGAGCAGACAGTCCAAATCC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6425&#8211;6445</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_11F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTGTAGCCCCCACCTTTC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6337&#8211;6356</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_11R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TAGCTCTTCCTGGCAGTGCC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7112&#8211;7132</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_12F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAAATTGAGGCCACYAAAAAGCTAC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6095&#8211;6929</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.4_12R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGGACTGGCGCTTTYAACACG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7439&#8211;7459</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-01243-t002" orientation="portrait"><object-id pub-id-type="pii">viruses-17-01243-t002_Table 2</object-id><label>Table 2</label><caption><p>Oligonucleotide panel for GII.7 genotyping (average fragment length, 1000 bp).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer Region</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tm Hybridization</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_1F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GTGAATGAAGATGGCGTCTAACGA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_1R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCAAYTCAAAATCACCTATCAGGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">980&#8211;1004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_2F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GGACGTTTGCAGGYATAGTRGAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">888&#8211;910</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_2R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TTAAAATGGTCYTTCCACATGTCRG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1914&#8211;1939</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_3F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAGGCGTGTTCTAGGAGAGTTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1828&#8211;1850</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_3R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTTGGCYTCTTCCTCTTCACAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2823&#8211;2845</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_4F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAGTTCAAGAGAATYAGGGAAGAAAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2708&#8211;2733</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_4R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TYATGAGAGAYCAGTTGAGRCCCTT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3750&#8211;3774</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_5F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CACCTACTGTGGWGCCCCAAT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3582&#8211;3603</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_5R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ARGAGTGAGCTTGGACWACATCTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4550&#8211;4574</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_6F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GTCATCTCAGTCCAGGARGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4435&#8211;4455</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_6R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGCTGTGAACGCGTTCCCAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5406&#8211;5426</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_7F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAAGCTCCTGCAGGTGAGTTY</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5250&#8211;5270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_7R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACTGGTGGRGACCARTAYGCC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6150&#8211;6170</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_8F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTACCAGAGCCCATGAAGCYAAC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6120&#8211;6143</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_8R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CATATGAAGCAGACTGCAYAGG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7072&#8211;7094</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_9F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATGCCGCRAGGGGYTCTGTY</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6951&#8211;6971</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_9.1R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTCTTCGCCCAYYTSCGTAR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7433&#8211;7452</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NV_GII.7_9.2R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGRTTTAGTGAAAAGATYRRTTAGGAAAG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7467&#8211;7495</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-01243-t003" orientation="portrait"><object-id pub-id-type="pii">viruses-17-01243-t003_Table 3</object-id><label>Table 3</label><caption><p>Results of cycle threshold (Ct) determination using real-time PCR (reagent kit&#8212;AmpliSens<sup>&#174;</sup> Norovirus GI-GII-FL, Central Scientific Research Institute of Epidemiology, Moscow, Russian Federation) (Target IPC&#8212;Internal Positive Control; Target GII&#8212;Genogroup GII).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ct IPC<break/>(Mean)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ct GII <break/>(Mean)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Med. Coverage<break/>Full-Length Sequence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AC Numbers, <break/>NCBI GenBank</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">2/GII.4[P16]</td><td align="center" valign="middle" rowspan="1" colspan="1">28.97</td><td align="center" valign="middle" rowspan="1" colspan="1">14.42</td><td align="center" valign="middle" rowspan="1" colspan="1">1621</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746275.1">PV746275.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4/GII.4[P16]</td><td align="center" valign="middle" rowspan="1" colspan="1">29.26</td><td align="center" valign="middle" rowspan="1" colspan="1">19.27</td><td align="center" valign="middle" rowspan="1" colspan="1">223</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746276.1">PV746276.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1629/GII.4[P16]</td><td align="center" valign="middle" rowspan="1" colspan="1">29.48</td><td align="center" valign="middle" rowspan="1" colspan="1">27.67</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1630/GII.4[P16]</td><td align="center" valign="middle" rowspan="1" colspan="1">29.95</td><td align="center" valign="middle" rowspan="1" colspan="1">22.06</td><td align="center" valign="middle" rowspan="1" colspan="1">162</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746277.1">PV746277.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1987/GII.4[P16]</td><td align="center" valign="middle" rowspan="1" colspan="1">29.33</td><td align="center" valign="middle" rowspan="1" colspan="1">21.42</td><td align="center" valign="middle" rowspan="1" colspan="1">406</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746278.1">PV746278.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28/GII.7[P7]</td><td align="center" valign="middle" rowspan="1" colspan="1">30.57</td><td align="center" valign="middle" rowspan="1" colspan="1">23.47</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV806172.1">PV806172.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29/GII.7[P7]</td><td align="center" valign="middle" rowspan="1" colspan="1">29.75</td><td align="center" valign="middle" rowspan="1" colspan="1">14.13</td><td align="center" valign="middle" rowspan="1" colspan="1">900</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV746280.1">PV746280.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30/GII.7[P7]</td><td align="center" valign="middle" rowspan="1" colspan="1">30.17</td><td align="center" valign="middle" rowspan="1" colspan="1">19.55</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV806173.1">PV806173.1</ext-link></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31/GII.7[P7]</td><td align="center" valign="middle" rowspan="1" colspan="1">30.91</td><td align="center" valign="middle" rowspan="1" colspan="1">19.87</td><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="PV806174.1">PV806174.1</ext-link></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38/GII.7[P7]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8212;</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>